Assenagon Asset Management S.A. Has $697.91 Million Position in Synopsys, Inc. $SNPS

Assenagon Asset Management S.A. boosted its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 48.3% during the first quarter, HoldingsChannel.com reports. The fund owned 1,760,256 shares of the semiconductor company’s stock after purchasing an additional 573,377 shares during the period. Synopsys accounts for 1.1% of Assenagon Asset Management S.A.’s portfolio, making the stock its 14th largest holding. Assenagon Asset Management S.A.’s holdings in Synopsys were worth $697,906,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Empirical Asset Management LLC bought a new stake in shares of Synopsys in the 3rd quarter worth about $773,000. China Universal Asset Management Co. Ltd. lifted its holdings in Synopsys by 31.8% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock valued at $6,957,000 after purchasing an additional 3,575 shares during the last quarter. SeaTown Holdings Pte. Ltd. boosted its position in Synopsys by 55.9% in the fourth quarter. SeaTown Holdings Pte. Ltd. now owns 22,300 shares of the semiconductor company’s stock valued at $10,475,000 after buying an additional 8,000 shares in the last quarter. Norges Bank acquired a new position in Synopsys in the fourth quarter valued at about $730,197,000. Finally, Douglas Lane & Associates LLC grew its stake in Synopsys by 5,701.2% during the fourth quarter. Douglas Lane & Associates LLC now owns 48,730 shares of the semiconductor company’s stock worth $22,889,000 after buying an additional 47,890 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Stock Performance

SNPS stock opened at $461.50 on Wednesday. The company has a 50 day moving average price of $481.71 and a 200 day moving average price of $462.29. Synopsys, Inc. has a fifty-two week low of $376.18 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The stock has a market capitalization of $88.37 billion, a PE ratio of 106.83, a price-to-earnings-growth ratio of 2.73 and a beta of 1.22.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same period last year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the stock a “buy” rating in a report on Wednesday, February 25th. BNP Paribas Exane increased their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. Berenberg Bank set a $633.00 price target on Synopsys in a report on Wednesday, May 27th. Stifel Nicolaus lifted their price objective on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Ten research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Piper Sandler upgraded Synopsys to Overweight and lifted its price target, citing stronger IP business prospects and potential tailwinds from Intel foundry activity and Apple-related opportunities. Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Positive Sentiment: Commentary continues to highlight Synopsys as a strong AI-era semiconductor software name, with recurring revenue, expanding AI-driven design tools, and IP licensing viewed as competitive advantages. Synopsys vs. Applied Digital: Which AI Stock Has an Edge Right Now?
• Positive Sentiment: Several recent articles frame the stock’s pullback as potentially attractive, with some analysts/model-driven commentary suggesting meaningful upside from current levels. Synopsys Eyes 23% Upside Despite Recent Pullback
• Neutral Sentiment: Additional coverage focused on broader Wall Street research-call roundups and general analyst optimism for Synopsys, which reinforces sentiment but does not add a new company-specific catalyst. Here Are Tuesday’s Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and More

Insider Activity

In related news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by company insiders.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.